Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Sio Gene Therapies Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 48 | −6 |
| Shares | 18.4M | 80.0K | 21.3M | +3.04M (+16.6%) |
| Value | $39.9M | $174.0K | $27.6M | −$12.1M (−30.6%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Sio Gene Therapies Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Privium Fund Management B.V. | 1,806,542 | $2.37M | 0.47% |
| Cladis Investment Advisory, LLC | 1,204,000 | $1.55M | 1.25% |
| Clearline Capital LP | 218,506 | $282.0K | 0.04% |
| Jane Street Group, LLC | 23,259 | $30.0K | 0.00% |
| UBS Group AG | 20,613 | $26.0K | 0.00% |
| Goldman Sachs Group Inc | 17,355 | $22.0K | 0.00% |
| FMR LLC | 1,000 | $1.00K | 0.00% |
Sold out (13)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Opaleye Management Inc. | 955,000 | $2.07M |
| Bank of Montreal | 438,907 | $935.0K |
| Marshall Wace, LLP | 47,537 | $103.0K |
| Prelude Capital Management, LLC | 34,000 | $74.0K |
| ExodusPoint Capital Management, LP | 21,407 | $46.0K |
| Royal Bank of Canada | 12,500 | $27.0K |
| Qube Research & Technologies Ltd | 11,920 | $26.0K |
| SG3 Management, LLC | 9,230 | $20.0K |
| TCI Wealth Advisors, Inc. | 1,400 | $3.00K |
| JPMorgan Chase & Co | 1,015 | $2.00K |
| Focused Wealth Management, Inc | 500 | $1.00K |
| Wolff Wiese Magana LLC | 400 | $1.00K |
| Gerber Kawasaki Wealth & Investment Management | 5 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 80,000 | $174.0K |